Heartflow, Inc. Common Stock

HTFLNASDAQHealthcare● Active

$28.79

+$0.69(+2.45%)

Market Cap$2.5B

P/E Ratio—

52W High$41.223

52W Low$20.13

Avg Volume1.3M

Open$28.79

Beta1.91

Overview

Heartflow, Inc. Common Stock (HTFL) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · HTFL · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.06

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 6%Active transactions only · RSU vesting excluded94% Sell ↓

Heartflow, Inc. Common Stock insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

HTFL insider buying and selling by quarter

HTFL insider selling · HTFL insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

7.0M3.5M0

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · HTFL ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

HTFL executive sell shares · HTFL board member insider trading · HTFL insider trading SEC filing

Showing 41 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 18, 2026	Rogers Campbell Chief Medical Officer	Option	9,219	$19.00	$175K	87,950	Form 4
May 18, 2026	Rogers Campbell Chief Medical Officer	Sale	9,219	$28.34	$261K	78,731	Form 4
May 11, 2026	Farquhar John C.M. CEO · Director	Sale	22,562	$29.12	$657K	519,397	Form 4
May 6, 2026	Rogers Campbell Chief Medical Officer	Other	1,634	$30.29	$49K	79,368	Form 4
May 7, 2026	Rogers Campbell Chief Medical Officer	Other	637	$29.98	$19K	78,731	Form 4
May 6, 2026	Farquhar John C.M. CEO · Director	Other	5,300	$30.29	$161K	543,863	Form 4
May 7, 2026	Farquhar John C.M. CEO · Director	Other	1,904	$29.98	$57K	541,959	Form 4
Apr 28, 2026	Bain Capital Life Sciences Investors, LLC 10 percent owner	Sale	254,110	$30.51	$7.75M⚡	10,194,048	Form 4
Apr 29, 2026	Bain Capital Life Sciences Investors, LLC 10 percent owner	Sale	797,133	$29.37	$23.41M⚡	9,396,915	Form 4
Apr 30, 2026	Bain Capital Life Sciences Investors, LLC 10 percent owner	Sale	892,533	$29.18	$26.04M⚡	8,504,382	Form 4
Apr 30, 2026	Bain Capital Life Sciences Investors, LLC 10 percent owner	Sale	56,224	$30.05	$1.69M⚡	8,448,158	Form 4
Apr 10, 2026	Farquhar John C.M. CEO · Director	Sale	22,562	$26.72	$603K	549,163	Form 4
Apr 1, 2026	Rogers Campbell Chief Medical Officer	Option	6,849	$2.22	$15K	145,535	Form 4
Apr 1, 2026	Rogers Campbell Chief Medical Officer	Option	40,766	$2.22	$91K	138,686	Form 4
Apr 1, 2026	Rogers Campbell Chief Medical Officer	Option	19,111	$2.22	$42K	97,920	Form 4
Apr 1, 2026	Rogers Campbell Chief Medical Officer	Sale	64,533	$24.64	$1.59M⚡	81,002	Form 4
Apr 1, 2026	Rogers Campbell Chief Medical Officer	Option	291	$8.33	$2K	78,809	Form 4
Mar 24, 2026	Lightcap Jeffrey C Director	Other	206,261	—	—	246,261	Form 4
Mar 19, 2026	Rogers Campbell Chief Medical Officer	Option	47,615	$2.22	$106K	143,051	Form 4
Mar 19, 2026	Rogers Campbell Chief Medical Officer	Option	19,402	$2.22	$43K	95,436	Form 4
Mar 19, 2026	Rogers Campbell Chief Medical Officer	Sale	64,533	$25.69	$1.66M⚡	78,518	Form 4
Mar 18, 2026	Farquhar John C.M. CEO · Director	Sale	9,725	$25.00	$243K	571,725	Form 4
Mar 11, 2026	BARABE TIMOTHY C Director	Option	8,667	$2.22	$19K	179,521	Form 4
Mar 6, 2026	Farquhar John C.M. CEO · Director	Award	2,631	$16.15	$42K	594,287	Form 4
Mar 10, 2026	Farquhar John C.M. CEO · Director	Sale	12,837	$22.66	$291K	581,450	Form 4

Rogers Campbell

Chief Medical Officer

Option

Date

May 18

9,219

Price

$19.00

Value

$175K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Sale

Date

May 18

9,219

Price

$28.34

Value

$261K

View Form 4 on SEC.gov

Farquhar John C.M.

CEO · Director

Sale

Date

May 11

22,562

Price

$29.12

Value

$657K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Other

Date

May 6

1,634

Price

$30.29

Value

$49K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Other

Date

May 7

637

Price

$29.98

Value

$19K

View Form 4 on SEC.gov

Farquhar John C.M.

CEO · Director

Other

Date

May 6

5,300

Price

$30.29

Value

$161K

View Form 4 on SEC.gov

Farquhar John C.M.

CEO · Director

Other

Date

May 7

1,904

Price

$29.98

Value

$57K

View Form 4 on SEC.gov

Bain Capital Life Sciences Investors, LLC

10 percent owner

Sale

Date

Apr 28

254,110

Price

$30.51

Value

$7.75M ⚡

View Form 4 on SEC.gov

Bain Capital Life Sciences Investors, LLC

10 percent owner

Sale

Date

Apr 29

797,133

Price

$29.37

Value

$23.41M ⚡

View Form 4 on SEC.gov

Bain Capital Life Sciences Investors, LLC

10 percent owner

Sale

Date

Apr 30

892,533

Price

$29.18

Value

$26.04M ⚡

View Form 4 on SEC.gov

Bain Capital Life Sciences Investors, LLC

10 percent owner

Sale

Date

Apr 30

56,224

Price

$30.05

Value

$1.69M ⚡

View Form 4 on SEC.gov

Farquhar John C.M.

CEO · Director

Sale

Date

Apr 10

22,562

Price

$26.72

Value

$603K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Option

Date

Apr 1

6,849

Price

$2.22

Value

$15K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Option

Date

Apr 1

40,766

Price

$2.22

Value

$91K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Option

Date

Apr 1

19,111

Price

$2.22

Value

$42K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Sale

Date

Apr 1

64,533

Price

$24.64

Value

$1.59M ⚡

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Option

Date

Apr 1

291

Price

$8.33

Value

$2K

View Form 4 on SEC.gov

Lightcap Jeffrey C

Director

Other

Date

Mar 24

206,261

Price

—

Value

—

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Option

Date

Mar 19

47,615

Price

$2.22

Value

$106K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Option

Date

Mar 19

19,402

Price

$2.22

Value

$43K

View Form 4 on SEC.gov

Rogers Campbell

Chief Medical Officer

Sale

Date

Mar 19

64,533

Price

$25.69

Value

$1.66M ⚡

View Form 4 on SEC.gov

Farquhar John C.M.

CEO · Director

Sale

Date

Mar 18

9,725

Price

$25.00

Value

$243K

View Form 4 on SEC.gov

BARABE TIMOTHY C

Director

Option

Date

Mar 11

8,667

Price

$2.22

Value

$19K

View Form 4 on SEC.gov

Farquhar John C.M.

CEO · Director

Award

Date

Mar 6

2,631

Price

$16.15

Value

$42K

View Form 4 on SEC.gov

Farquhar John C.M.

CEO · Director

Sale

Date

Mar 10

12,837

Price

$22.66

Value

$291K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About HTFL insider trading

HTFL insider trades

Heartflow, Inc. Common Stock (HTFL) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Rogers Campbell (Chief Medical Officer), Farquhar John C.M. (CEO · Director), Bain Capital Life Sciences Investors, LLC (10 percent owner). Over the past 12 months, 5 insiders have filed transactions with the SEC. HTFL insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Heartflow, Inc. Common Stock's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

HTFL insider trading · 5 questions

The insiders of Heartflow, Inc. Common Stock (HTFL) include executives and directors such as Rogers Campbell (Chief Medical Officer), Farquhar John C.M. (CEO · Director), Bain Capital Life Sciences Investors, LLC (10 percent owner), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

HTFL board member insider tradingwho are HTFL insidersHTFL insider rosterHeartflow, Inc. Common Stock executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026